Hepatic artery injection of ¹³¹I-labelled metuximab combined with chemoembolization for intermediate hepatocellular carcinoma: a prospective nonrandomized study.

European Journal of Nuclear Medicine and Molecular Imaging
Lu WuMeng-Chao Wu

Abstract

Hepatocellular carcinoma (HCC) is the fifth and seventh most common cause of cancer in men and women, respectively. Transcatheter arterial chemoembolization (TACE) is the standardized therapy for the intermediate stage of HCC. However, the 3-year overall survival remains low (<30 %) in these patients. Thus, there is a critical need for the development of treatment modalities to improve the survival rate. This study aimed to evaluate whether the combination of (131)I-metuximab with chemoembolization could improve treatment efficiency. Between January 2009 and January 2010, a prospective two-arm nonrandomized study was performed in patients with intermediate HCC. Of 138 patients, 68 (combination therapy group) received 132 courses of intraarterial (131)I-metuximab injections combined with chemoembolization (mean 1.94 per patient, median 2, range 1-2), followed by 152 sessions of TACE (mean 2.24 per patient, median 2, range 0-4). The remaining 70 patients (monotherapy group) received 296 sessions of TACE (mean 4.23 per patient, median 4, range 1-7). The overall median survival times for the combination therapy group and the group treated only with TACE were 26.7 months (95 % CI 20.7-31.3 months) and 20.6 months (95 % CI 15.3-24.7 ...Continue Reading

References

Jan 1, 1981·Cancer·A B MillerA Winkler
Aug 31, 2000·Radiology·S KatyalR L Baron
Nov 30, 2002·European Journal of Nuclear Medicine and Molecular Imaging·Zhao-Chong ZengGuo-Liang Jiang
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Josep M Llovet, Jordi Bruix
Apr 17, 2003·Current Topics in Developmental Biology·Bryan P Toole
Oct 17, 2003·World Journal of Gastroenterology : WJG·Yu LiZhi-Nan Chen
Mar 17, 2006·Cancer·Maria A Hawkins, Laura A Dawson
May 13, 2006·International Journal of Radiation Oncology, Biology, Physics·Zhi-Nan ChenPing Zhu
Jan 30, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jing XuZhi-Nan Chen
May 15, 2008·Journal of the National Cancer Institute·Josep M LlovetUNKNOWN Panel of Experts in HCC-Design Clinical Trials
Feb 24, 2009·Lancet·Jordi Bruix, Josep M Llovet
Jun 25, 2010·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Lorenzo Andreana, Andrew K Burroughs
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Sep 24, 2011·Seminars in Radiation Oncology·Mary Feng, Edgar Ben-Josef
Oct 14, 2011·The New England Journal of Medicine·Hashem B El-Serag
Oct 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martina Steiner, Dario Neri
Nov 24, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Seanthan SenthilnathanRiad Salem

❮ Previous
Next ❯

Citations

Jan 1, 2014·World Journal of Gastroenterology : WJG·Qing HeAn-Ren Kuang
Jan 19, 2016·BioMed Research International·Cory D BovenziJoseph M Curry
Oct 9, 2014·Journal of Zhejiang University. Science. B·Chai-Hong YeongKwan-Hoong Ng
Aug 14, 2009·Journal of Experimental & Clinical Cancer Research : CR·Ping WuEdward J Mills
Jan 23, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Meng LuHuijie Bian
Oct 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·Wei-Hsiang LinDing-Shinn Chen
Oct 13, 2017·Physiology·Shiren SunQi Qian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.